Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro

Abstract

It has been suggested that clec14a may be involved in tumor angiogenesis. However, a molecular mechanism has not been clearly identified. In this study, we show for the first time that C-type lectin-like domain (CTLD) of clec14a may be important for regulating cell migration and filopodia formation. Using phage display technology, recombinant human antibodies specific to the CTLDs of human and mouse clec14a (clec14a-CTLD (immunoglobulin G) IgG) were selected. Functional assays using the antibodies showed that clec14a-CTLD IgGs specifically blocked endothelial cell migration and tube formation without affecting cell viability or activation. Further, clec14a-CTLD IgGs inhibited clec14a-mediated cell–cell contact by blocking interaction between CTLDs. Finally, clec14a cross-linking by the clec14a-CTLD IgGs significantly downregulated clec14a expression on the surface of endothelial cells. These results strongly suggest that the clec14a-CTLD may be a key domain in angiogenesis, and that clec14a-CTLD IgGs specifically inhibit angiogenesis by modulating CTLD-mediated cell interactions and clec14a expression on the surface of endothelial cells.

DOI: 10.1038/onc.2013.156

Extracted Key Phrases

9 Figures and Tables

02004006002014201520162017
Citations per Year

427 Citations

Semantic Scholar estimates that this publication has 427 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@inproceedings{Ki2013HumanAT, title={Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro}, author={Min Kyung Ki and Mee Hyun Jeoung and J R Choi and S G Rho and Y M Kwon and H J Shim and J H Chung and Hyo Jeong Hong and Byeong Doo Song and Seongsu Lee}, booktitle={Oncogene}, year={2013} }